Lifibrate is an antihyperlipidemic agent classified as a potent hepatic peroxisome proliferator-activated receptor agonist used in the management of hypercholesterolemia and hypertriglyceridemia. This… Read more
Lifibrate is an antihyperlipidemic agent classified as a potent hepatic peroxisome proliferator-activated receptor agonist used in the management of hypercholesterolemia and hypertriglyceridemia. This category provides access to high-quality reference standards of the active pharmaceutical ingredient, alongside a comprehensive selection of pharmacopeial and non-pharmacopeial impurities, degradation products, and metabolites. Pharmaceutical laboratories rely on these compounds for critical analytical testing, including impurity profiling and the validation of analytical methods to ensure regulatory compliance. Furthermore, stable isotope-labelled compounds within this collection serve as essential internal standards for mass spectrometry and quantitative analysis, enabling precise identification and quantification of the drug and its related substances throughout the drug development and quality control lifecycle.